{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T21:12:03Z","timestamp":1768079523560,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T00:00:00Z","timestamp":1356048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s12094-012-0974-0","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T12:22:47Z","timestamp":1356006167000},"page":"602-607","source":"Crossref","is-referenced-by-count":11,"title":["Three or four fractions per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma. The long-term results on vaginal relapses and toxicity"],"prefix":"10.1007","volume":"15","author":[{"given":"I.","family":"Valduvieco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"Rovirosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Herreros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Romera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"R\u00edos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ascaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"S\u00e1nchez-Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Arenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pahisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Biete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,21]]},"reference":[{"key":"974_CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0167-8140(00)00171-7","volume":"1","author":"RG Pearcey","year":"2000","unstructured":"Pearcey RG, Petereit DG (2000) Postoperative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer. Radiother Oncol 1:17\u201322","journal-title":"Radiother Oncol"},{"key":"974_CR2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1525-1438.1994.04020084.x","volume":"4","author":"P Elliot","year":"1994","unstructured":"Elliot P, Green D, Coates A et al (1994) The efficacy of postoperative vaginal radiation in preventing vaginal recurrence in endometrial cancer. Int Gynecol Cancer 4:84\u201393","journal-title":"Int Gynecol Cancer"},{"key":"974_CR3","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","volume":"355","author":"CL Creutzberg","year":"2000","unstructured":"Creutzberg CL, van Putten WL, Koper PC et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study group. Postoperative radiation therapy in endometrial carcinoma. Lancet 355:1404\u20131411","journal-title":"Lancet"},{"key":"974_CR4","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","volume":"375","author":"RA Nout","year":"2010","unstructured":"Nout RA, Smit VT, Putter H et al (2010) Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. PORTEC Study group. Lancet 375:816\u2013823","journal-title":"Lancet"},{"key":"974_CR5","doi-asserted-by":"crossref","unstructured":"Gazta\u00f1aga M, Cambeiro M, Villafranca E et al (2012) Long-term results of 1-week intravaginal high-dose-rate brachytherapy alone for endometrial cancer. Brachytherapy 11:119\u2013124","DOI":"10.1016\/j.brachy.2011.05.004"},{"key":"974_CR6","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ijrobp.2010.06.001","volume":"81","author":"A Rovirosa","year":"2011","unstructured":"Rovirosa A, Ascaso C, S\u00e1nchez-Reyes A et al (2011) Three or four fractions of 4\u20135\u00a0gy per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma. Int J Radiat Oncol Biol Phys 81:418\u2013423","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"974_CR7","doi-asserted-by":"crossref","unstructured":"Rovirosa A, Valduvieco I, Ascaso C et al (2012) Daily schedule for high-dose-rate brachytherapy in postoperative treatment of endometrial carcinoma. Clin Transl Oncol. doi: 10.1007\/s12094-012-0893-0","DOI":"10.1007\/s12094-012-0893-0"},{"key":"974_CR8","unstructured":"Sobin LH, Wittekind CH (eds) (2002) TMN Classification of Malignant Tumours. Union Internationale Contre le Cancer. Wiley-Liss, Washington, pp 160\u2013164"},{"key":"974_CR9","unstructured":"ICRU (1985) Report no. 38, dose and volume specification for reporting intracavitary therapy in gynaecology. In: Chassagne D, Dutreix A, Almond P, Burgers J, Busch M, Joslin C (eds) International commissioning on radiation units and measurements. Bethesda"},{"key":"974_CR10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0167-8140(95)01548-U","volume":"35","author":"Late effects consensus conference","year":"1995","unstructured":"Late effects consensus conference (1995) RTOG\/EORTC. Radiother Oncol 35:5\u20137","journal-title":"Radiother Oncol"},{"key":"974_CR11","doi-asserted-by":"crossref","unstructured":"(1995) LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 31:1049\u20131091 (classification)","DOI":"10.1016\/0360-3016(95)90159-0"},{"key":"974_CR12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12094-012-0794-2","volume":"14","author":"JL Guinot","year":"2012","unstructured":"Guinot JL, P\u00e9rez-Calatayud J, Azcoaga JM et al (2012) Consensus on treatment of endometrium carcinoma with brachytherapy. SEOR and the SEFM Brachytherapy Groups. Clin Transl Oncol 14:263\u2013270","journal-title":"Clin Transl Oncol"},{"key":"974_CR13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0360-3016(00)00497-1","volume":"48","author":"S Nag","year":"2000","unstructured":"Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D (2000) The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 48:201\u2013211","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"974_CR14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brachy.2011.08.005","volume":"11","author":"W Small Jr","year":"2012","unstructured":"Small W Jr, Beriwal S, Demanes DJ et al (2012) American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. American Brachytherapy Society. Brachytherapy 11:58\u201367","journal-title":"Brachytherapy"},{"key":"974_CR15","first-page":"1356","volume":"20","author":"L Eiriksson","year":"2010","unstructured":"Eiriksson L, Cuartero J, Steed H et al (2010) Assessment of outcomes in surgically staged I\/II endometrial adenocarcinoma patients treated with postoperative vaginal vault radiotherapy only. Int J Gynecol Cancer 20:1356\u20131362","journal-title":"Int J Gynecol Cancer"},{"key":"974_CR16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijrobp.2010.10.071","volume":"82","author":"AY Bahng","year":"2012","unstructured":"Bahng AY, Dagan A, Bruner DW, Lin LL (2012) Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer. Int J Radiat Oncol Biol Phys 82:667\u2013673","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"974_CR17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ijrobp.2010.02.058","volume":"80","author":"LC Friedman","year":"2011","unstructured":"Friedman LC, Abdallah R, Schluchter M, Panneerselvam A, Kunos CA (2011) Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer. Int J Radiat Oncol Biol Phys 80:751\u2013757","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0974-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-012-0974-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0974-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:51:34Z","timestamp":1559447494000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-012-0974-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,21]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["974"],"URL":"https:\/\/doi.org\/10.1007\/s12094-012-0974-0","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,21]]}}}